Sign in
Taking peopleNo phase

MPS (RaDiCo Cohort) (RaDiCo-MPS)

Key facts

Who runs it
Institut National de la Santé Et de la Recherche Médicale, France
Where
France23 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
20 Dec 2017
Expected to end
Dec 2026
Type of study
Observational
Record updated
11 February 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Confirmed diagnosis of MPS based on clinically relevant enzyme deficiency, with abnormally elevated GAG urinary excretion and/or identification of pathogenic mutations
  • Signed informed consent or parents/guardian non-opposition for deceased patients (minor or protected major); There are no non-inclusion criteria

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics
Record updated
11 February 2026